124 related articles for article (PubMed ID: 6364671)
1. Relation of immunoreactive gastric inhibitory polypeptide to changes in glycaemic control and B cell function in type 1 (insulin-dependent) diabetes mellitus.
Krarup T; Madsbad S; Regeur L; Faber OK; Tronier B
Acta Endocrinol (Copenh); 1984 Feb; 105(2):221-5. PubMed ID: 6364671
[TBL] [Abstract][Full Text] [Related]
2. Immunoreactive gastric inhibitory polypeptide response to a meal during the first eighteen months after diagnosis of type 1 (insulin dependent) diabetes mellitus.
Krarup T; Madsbad S; Moody AJ
J Clin Endocrinol Metab; 1985 Jan; 60(1):120-5. PubMed ID: 3880559
[TBL] [Abstract][Full Text] [Related]
3. Gastric inhibitory polypeptide in newly diagnosed ketotic type I (insulin-dependent) diabetics.
Krarup T; Madsbad S; Moody AJ
Acta Med Scand; 1988; 223(5):437-41. PubMed ID: 3287838
[TBL] [Abstract][Full Text] [Related]
4. Diminished immunoreactive gastric inhibitory polypeptide response to a meal in newly diagnosed type I (insulin-dependent) diabetics.
Krarup T; Madsbad S; Moody AJ; Regeur L; Faber OK; Holst JJ; Sestoft L
J Clin Endocrinol Metab; 1983 Jun; 56(6):1306-12. PubMed ID: 6341393
[TBL] [Abstract][Full Text] [Related]
5. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
[TBL] [Abstract][Full Text] [Related]
6. The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus.
Elahi D; Andersen DK; Muller DC; Tobin JD; Brown JC; Andres R
Diabetes; 1984 Oct; 33(10):950-7. PubMed ID: 6383904
[TBL] [Abstract][Full Text] [Related]
7. Effect of exogenous insulin on fasting serum levels of gastric inhibitory polypeptide (GIP) in juvenile diabetes.
Talaulicar M; Ebert R; Willms B; Creutzfeldt W
Clin Endocrinol (Oxf); 1981 Feb; 14(2):175-80. PubMed ID: 7021006
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of immunoreactive gastric inhibitory polypeptide in the plasma of newly diagnosed type 1 (insulin-dependent) diabetics.
Krarup T; Holst JJ; Madsbad S
Acta Endocrinol (Copenh); 1987 Jan; 114(1):74-83. PubMed ID: 3544634
[TBL] [Abstract][Full Text] [Related]
9. Gastric inhibitory polypeptide hypersecretion in diabetes mellitus: effect of sulfonylurea treatment.
Coxe JS; O'Dorisio TM; Cataland S; Crockett SE
J Clin Endocrinol Metab; 1981 May; 52(5):1002-5. PubMed ID: 7014585
[TBL] [Abstract][Full Text] [Related]
10. Serum gastric inhibitory polypeptide (GIP) in duodenal ulcer disease: relationship to glucose tolerance, insulin, and gastrin release.
Arnold R; Creutzfeldt W; Ebert R; Becker HD; Börger HW; Schafmayer A
Scand J Gastroenterol; 1978; 13(1):41-7. PubMed ID: 635445
[TBL] [Abstract][Full Text] [Related]
11. Effect of porcine gastric inhibitory polypeptide on beta-cell function in type I and type II diabetes mellitus.
Krarup T; Saurbrey N; Moody AJ; Kühl C; Madsbad S
Metabolism; 1987 Jul; 36(7):677-82. PubMed ID: 3298936
[TBL] [Abstract][Full Text] [Related]
12. Effect of serial test meals on plasma immunoreactive GIP in non-insulin dependent diabetic patients and non-diabetic controls.
Groop PH; Fyhrquist F; Groop LC
Scand J Clin Lab Invest; 1985 Apr; 45(2):115-22. PubMed ID: 3890129
[TBL] [Abstract][Full Text] [Related]
13. The effect of insulin deprivation on fasting levels of 5000 dalton gastric inhibitory polypeptide in type 1 (insulin-dependent) diabetics.
Krarup T; Madsbad S; Regeur L; Alberti KG; Faber OK; Kurtz A
Diabete Metab; 1985 Dec; 11(6):364-7. PubMed ID: 3910488
[TBL] [Abstract][Full Text] [Related]
14. Gastric inhibitory polypeptide (GIP) in maturity-onset diabetes mellitus.
Crockett SE; Mazzaferri EL; Cataland S
Diabetes; 1976 Oct; 25(10):931-5. PubMed ID: 976601
[TBL] [Abstract][Full Text] [Related]
15. Effects of intravenously infused porcine GIP on serum insulin, plasma C-peptide, and pancreatic polypeptide in non-insulin-dependent diabetes in the fasting state.
Amland PF; Jorde R; Aanderud S; Burhol PG; Giercksky KE
Scand J Gastroenterol; 1985 Apr; 20(3):315-20. PubMed ID: 3890139
[TBL] [Abstract][Full Text] [Related]
16. Hormonal enteroinsular axis in newborn infants of insulin-treated diabetic mothers.
Knip M; Kääpä P; Koivisto M
J Clin Endocrinol Metab; 1993 Nov; 77(5):1340-4. PubMed ID: 8077330
[TBL] [Abstract][Full Text] [Related]
17. Effect of dietary fibre on blood glucose, plasma immunoreactive insulin, C-peptide and GIP responses in non insulin dependent (type 2) diabetics and controls.
Hagander B; Scherstén B; Asp NG; Sartor G; Agardh CD; Schrezenmeir J; Kasper H; Ahrén B; Lundquist I
Acta Med Scand; 1984; 215(3):205-13. PubMed ID: 6328896
[TBL] [Abstract][Full Text] [Related]
18. Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetes.
Højberg PV; Vilsbøll T; Zander M; Knop FK; Krarup T; Vølund A; Holst JJ; Madsbad S
Diabet Med; 2008 Nov; 25(11):1268-75. PubMed ID: 19046215
[TBL] [Abstract][Full Text] [Related]
19. Gastric inhibitory polypeptide (GIP) and insulin release in response to oral and intravenous glucose in uremic patients.
Lauritzen JB; Lauritsen KB; Olsen ME; Timmerman I
Metabolism; 1982 Nov; 31(11):1096-9. PubMed ID: 6752641
[TBL] [Abstract][Full Text] [Related]
20. Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function.
Verdonk CA; Rizza RA; Nelson RL; Go VL; Gerich JE; Service FJ
J Clin Invest; 1980 May; 65(5):1119-25. PubMed ID: 6988457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
